.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
UBS
Argus Health
Boehringer Ingelheim
Merck
Harvard Business School
QuintilesIMS
Cantor Fitzgerald
McKesson

Generated: January 17, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 199 55 190

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
PfizerTOVIAZfesoterodine fumarateTABLET, EXTENDED RELEASE;ORAL022030-001Oct 31, 2008ABRXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY, AND FREQUENCY
PfizerTOVIAZfesoterodine fumarateTABLET, EXTENDED RELEASE;ORAL022030-002Oct 31, 2008ABRXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY, AND FREQUENCY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist